万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生1>>儿科

INDIAN PEDIATRICS《印度儿科》 (官网投稿)

简介
  • 期刊简称INDIAN PEDIATR
  • 参考译名《印度儿科》
  • 核心类别 SCIE(2023版), 外文期刊,
  • IF影响因子
  • 自引率19.40%
  • 主要研究方向医学-PEDIATRICS 儿科

主要研究方向:

等待设置主要研究方向
医学-PEDIATRICS 儿科

INDIAN PEDIATRICS《印度儿科》(月刊). Indian Pediatrics (IP), the official publication of the Indian Academy of Pediatrics (IAP), is indexed by&...[显示全部]
征稿信息

万维提示:

1、投稿方式:在线投稿。

2、期刊网址:http://www.indianpediatrics.net/

https://www.springer.com/journal/13312

3、投稿网址:https://www.editorialmanager.com/inpe/

4、官网邮箱:jiap@nic.in

5、官网电话:+ 91-11-46052593

6、期刊刊期:月刊,一年出版12期。

202164日星期五

                             

 

投稿须知【官网信息】

 

Instructions to Authors

Indian Pediatrics, the official journal of the Indian Academy of Pediatrics, is a peer-reviewed journal with monthly circulation of print/e-copies to over 30,000 pediatrician members. The journal is being published regularly since 1964, and is indexed in PubMed, Current Contents/Clinical Medicine, Science Citation Index Expanded, Medline, Indian Science Abstracts, get CITED, POPLINE, CANCERLIT, TOXLINE, Psych Line and DERMLINE. The journal follows International Committee of Medical Journal Editors (ICMJE) Recommendations for the conduct, reporting, editing and publication of scholarly work in medical journals. Indian Pediatrics is also a member journal of Committee on Publication Ethics (COPE). The journal gives priority to reports of outstanding clinical work, as well as important contributions related to common and topical problems related to children and adolescents, especially those relevant to developing countries.  Papers reporting research in Pediatric surgery, Pediatric orthopedics, Pediatric ophthalmology, Pediatric dermatology and Pediatric radiology are also published.

Indian Pediatrics is also available full-text online at www.indianpediatrics.net (free HTML access) and at www.springer.com/medicine/pediatrics/journal/13312 (International edition). The journal does not charge any article processing fee.

Impact statistics and web presence: The Impact factor (2019) of Indian Pediatrics is 1.186. The journal website consistently receives more than 2.0 million hits per month.

Manuscript submission: Indian Pediatrics utilizes the online manuscript management and processing system of Editorial Manager for manuscripts. Please log in directly to the site https://www.editorialmanager.com/inpe , register (first visit only) and upload your manuscript as per on-screen instructions. All manuscript related queries should be through the website only. No e-mailed or hard copy manuscripts are entertained.

Criteria for Acceptance

All manuscripts should meet the following criteria: the material is original, study methods are ethical and appropriate, data are sound, conclusions are reasonable and supported by the data, and the information is important; the topic has general pediatric interest; and the article is written in reasonably good English. The article should be submitted in the style of Indian Pediatrics (vide infra). Manuscripts conforming to ICMJE guidelines [1] will also be accepted and enter the review process; however, if accepted, the final version would need to conform to the journal’s style. Manuscripts not prepared as per the journal guidelines or ICMJE guidelines would be sent back to authors without initiating the peer-review process. The current acceptance rate of submitted articles is around 20% overall, and 5% for Clinical case letters. All accepted manuscripts are subject to editorial modifications to suit the language and style of Indian Pediatrics. After modifications, they will be sent to the corresponding author for approval.

Review process: About half the submitted manuscripts are rejected after an initial Editorial board review. The usual reasons for rejection at this stage are insufficient originality, serious scientific or presentation flaws, major ethical issues, absence of a message, article not related to children or adolescents, not submitted in desired format, not of interest to majority of readers, or not in accordance with the current priorities of the journal. Decision on such papers is communicated to authors within two weeks. Remaining articles are sent to reviewers having sufficient experience on the subject, in a ‘masked fashion’. Manuscripts are reviewed with due respect for authors’ confidentiality. Authors should take care not to disclose their and their institution’s identity in the text of the ‘blinded manuscript.’  The peer reviewer identity is also kept confidential.

The time from submission to first decision varies from 2 weeks to 6 weeks depending on availability of reviewers, and timely response from them.

Categories of Articles

Articles can be submitted as Research Papers, Research Briefs, Research Letters, Review Articles, Drug reviews, Rational diagnostics, Perspective, Update, Images, Clinical Case Letters, Clinico-Pathological Conference, and Correspondence.

Original Research

Manuscripts reporting original research may be submitted as Research Paper, Research Brief or Research Letter.

Research Paper: The submission should report research relevant to clinical pediatrics including randomized clinical trials, other intervention studies, studies of screening and diagnostic tests, analytical cohort and case-control studies, systematic reviews and cost-effectiveness analyses. Descriptive studies, surveys, case records/series, pilot interventional studies, and secondary analyses of data are usually not preferred for this section.

Each manuscript should be accompanied with an 8-point structured abstract in not more than 250 words. The 8 subheadings of the structured abstract should be: background, objective, study design, participants, intervention, outcomes, results, and conclusion. The main text of the manuscript should be arranged in sections on Introduction, Methods, Results and Discussion. The authors should take care to avoid use of sub-headings in the Results or Discussion section. However, Methods section should always include a sub-heading of ‘Statistical analysis.’ Key messages should be provided at the end of the manuscript in a box under headings: ‘What is Already Known?’ and ‘What this Study Adds?.’ As far as possible, authors should restrict to a one line answer for each of these two queries. Number of tables and figures should be limited to a maximum of 4 and 2, respectively. Extra tables and figures, subject to clearance by editorial review process, may be made available only at the journal website, as Web table or Webfigure. The typical text length for such contributions is 2500 words (excluding title page, abstract, tables, figures, acknowledgments, key messages and references). Number of references should be limited to 25.

Research Brief: Descriptive observational studies, epidemiological assessments, and surveys are published as Research Briefs. Knowledge, attitude, practice (KAP) studies are generally not preferred. Some of the manuscripts submitted as ‘Research Papers’ may also be considered for publication under this section at the discretion of editors. A reasonably large series of cases can also be considered for this section. Abstract should be limited to 150 words, and structured using the following headings: Objective, Methods, Results, and Conclusions. The text should contain no more than 1500 words, up to 3 illustrations/tables and up to 15 recent references. The text should be arranged in order of Introduction, Methods, Results and Discussion. Also include a box entitled ‘What this Study Adds?’ highlighting the main result of the study.

The distinction between Research Brief and Research Paper is purely the journal’s prerogative and does not reflect on the originality of the research submitted. The manuscripts will be finally published under the heading of Research Papers.

Research Letter: These are reports of original research not exceeding 800 words of text and 10 references. They may have no more than five authors. Unstructured abstract of up to 50 words reporting the key findings should also be included. Letters must not duplicate other material published, submitted or planned to be submitted for publication. Although unstructured, the text should follow the general sequence of introduction, methods, results and discussion.

Clinical Material

Interesting Clinical observations may be shared through Clinical Case Letters or Images sections.

Clinical Case Letter: Clinical cases highlighting some unusual or new but “clinically relevant” aspects of a condition are published as Clinical Case letters. Such reports should highlight some new or unusual aspect regarding etiopathogenesis, diagnosis or management of a condition that adds to the existing body of knowledge. Rarity of the reported condition alone will not be a criterion for acceptance. Genetic syndromes not reporting novel mutations explaining pathophysiology and/or genotype-phenotype correlation will be sent back to authors without initiating the peer review process. Minor or clinically insignificant variations of rare but well-known disorders are also not preferred. The text should not exceed 800 words and should be in running text with unlabeled paragraphs sequentially containing Introduction, clinical-description, and discussion. Include a maximum of 6 references. Only one very relevant figure is allowed. Only color photographs should be submitted; black-and-white images will not be entertained. Color images will be published only in the web-version of the journal; for print version, these will be converted to black and white (For details, see below under Figures and Illustrations). Authors primarily reporting some visual clinical observation may consider submitting to the Images section instead of this section.

A maximum of three authors are permitted from a single department. Case letters involving more than one department can have one additional author from each department (not from subspecialties within the same department). Whenever there is a clinical image, patient’s written consent (or that of the next of kin) to publication must be obtained, and the same must be affirmed/stated on the Title page. The editorial board may ask for such a consent form at any time during the manuscript review process.

Images: Only clinical photographs with/without accompanying skiagrams or pathological images are considered for publication. Images of radiographs/histopathology slides alone (without accompanying clinical photograph) are not considered for this section. Image should clearly identify the condition and have the classical characteristics of the clinical condition. Clinical photograph of conditions that are very common, extremely rare, where diagnosis is obvious (e.g., penile agenesis), or where diagnosis is not possible on images alone would not be considered. A short text of about 150 words should be provided in two paragraphs; first paragraph having description of condition, and second paragraph discussing differential diagnosis and management. No references are needed. See guidelines for preparing and submitting figures/images(vide infra).

A maximum of two authors are permitted. Images of cases involving more than one department can have a maximum of three authors. The authors should ensure that images of similar nature have not been published earlier in Indian Pediatrics. Authors must obtain signed informed consent from the parent/legal guardian, and the same must be stated on the Title page. Such form should also be attached as a supplementary material while submitting the manuscript.

Reviews

The journal encourages submission of review articles addressing recent advances/controversies.  These may be submitted as either Review Papers, Drug Review, Update or Perspective. Please note that as a routine all review papers submitted to Indian Pediatrics undergo a plagiarism check, and the articles are promptly sent back for revision or rejected depending on the extent of similarity with the published literature.

Review Paper: State-of-the-art review articles with systematic, critical assessments of literature are published. The authors may consult the Editor-in-Chief before submitting such articles, as similar reviews may already be in submission. Normally, a review article on a subject already published in Indian Pediatrics in last five years is not accepted. The typical length for review articles is 2500-3000 words (excluding tables, figures, and references). An abstract of around 200 words with the following sections: Context (describing the clinical question or issue and its importance in clinical practice or public heath), Evidence acquisition (describing the data sources used, including the search strategies, years searched, and other sources), Results (major findings of the review with the greatest emphasis laid on the findings based on highest quality evidence), and Conclusions (emphasize how clinicians should apply current knowledge). The number of references should be limited to 50. Authors should take care to avoid excessive self-citation. The number of authors should usually be limited to three.

Drug Review: Indian Pediatrics publishes state of the art reviews on drugs/agents meant for therapeutic or prophylactic use in children. It is expected that the authors have sufficient credible experience in the related field. The following guidelines should be adhered to when preparing a drug review:

Drug/agent should be recently developed and should be available commercially(in India) for use in human subjects. Reviews related to agents under research and development, are generally not accepted.

Drug should preferably belong to a new class of drugs or having substantial difference in properties and not just an addition to the existing drugs having many similar properties/actions in that class/group of compounds.

The drug should have the potential to be used on a large scale for pediatric conditions. Drugs primarily catering to other medical fields (e.g. adult medicine, dermatology or surgical specialties) are not preferred.

The drug and related review should have the potential to influence practice, policy and research related issues.

The review should be a systematic, critical assessment of the literature and not just an elaboration of the information already provided by pharmaceutical companies.

Update: Short write-ups on recent modifications/revisions of standard Guidelines, Classifications or Recommendations issued by Global organizations on topics of interest to pediatricians are published in this section. The word limit is 1000 words, author limit is three, and a maximum of 2 tables and 10 references are allowed. An unstructured abstract of upto 50 words should also be included. It is preferable that the most relevant changes from the previous version are provided in a tabular form. The manuscript should preferably include an ‘Introduction’ detailing the current status of the disease/guideline and the need for the revision, important changes in the new version, and the implications of the changes.

Perspective: Articles should cover challenging and controversial topics of current interest in pediatric health care and the intersection between medicine and society. The related issues could be National, Regional (South East Asia) or Global. Though the articles are usually solicited, we welcome submissions and proposals from researchers and opinion-makers, provided they have sufficient credible experience and recognition on the subject for giving opinions. Some of the manuscripts submitted as ‘Review Articles’ may also be considered for publication under this section after editing, at the discretion of editors. The following guidelines need to be followed:

The number of authors should usually be limited to three.

The topic should be specific and related to child health in general.

Word limit: 2000 words and may include one figure and one table.

Unstructured abstract of up to 150 words.

The views should be supported by appropriate evidence and references. Number of references should be limited to a maximum of 25.

……

更多详情:

http://www.indianpediatrics.net/author1.htm


  • 万维QQ投稿交流群    招募志愿者

    版权所有 Copyright@2009-2015豫ICP证合字09037080号

     纯自助论文投稿平台    E-mail:eshukan@163.com


投稿问答最小化  关闭